L
Lars Öhman
Researcher at Novum
Publications - 19
Citations - 4281
Lars Öhman is an academic researcher from Novum. The author has contributed to research in topics: Glutamine & Glucocorticoid. The author has an hindex of 13, co-authored 19 publications receiving 4142 citations.
Papers
More filters
Journal ArticleDOI
Molecular basis of agonism and antagonism in the oestrogen receptor.
Andrzej M. Brzozowski,Ashley C. W. Pike,Zbigniew Dauter,Roderick E. Hubbard,Tomas Bonn,Owe Engström,Lars Öhman,Geoffrey L. Greene,Jan-Åke Gustafsson,Mats Carlquist +9 more
TL;DR: The crystal structures of the LBD of ER in complex with the endogenous oestrogen, 17β-oestradiol, and the selective antagonist raloxifene provide a molecular basis for the distinctive pharmacophore of the ER and its catholic binding properties.
Journal ArticleDOI
The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain RU-486 INDUCES A TRANSCONFORMATION THAT LEADS TO ACTIVE ANTAGONISM
Björn Kauppi,Clarissa G. Jakob,Mathias Färnegårdh,Jie Yang,Harri Ahola,Maria Alarcon,Karin Calles,Owe Engström,John M. Harlan,Steven W. Muchmore,Anna Karin Ramqvist,Susanne Thorell,Lars Öhman,Jonathan Greer,Jan-Åke Gustafsson,Jan Carlstedt-Duke,Mats Carlquist +16 more
TL;DR: All three RU-486 GR-LBD structures show that GR has a very flexible region between the end of helix 11 and the endof helix 12, and the subunits of the GR3 dimers are covalently connected via a disulfide bond between the Cys-736 residues in the two molecules.
Journal ArticleDOI
Physiology of cultured animal cells
TL;DR: It is suggested that proliferation of Spodoptera frugiperda (Sf9 insect cells), a normal cell line able to grow in a serum-free medium without any added growth factors, is regulated by autocrine growth factors and possibly by other regulatory mechanisms.
Journal ArticleDOI
Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase.
Barbro Ek-Rylander,Tomas Barkhem,Jenny Ljusberg,Lars Öhman,Kerstin Andersson,Göran Andersson +5 more
TL;DR: The recombinant PAP should be useful in future studies on the properties and regulation of the mammalian PAP enzyme, and was shown to be substituted with N-linked oligosaccharides.
Journal ArticleDOI
Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes
Peer B. Jacobson,Thomas W. von Geldern,Lars Öhman,Marie Österland,Jiahong Wang,Bradley A. Zinker,Denise Wilcox,Phong Nguyen,Amanda K Mika,Steven Fung,Thomas A. Fey,Annika Goos-Nilsson,Marlena Grynfarb,Tomas Barkhem,Kennan C. Marsh,David W. A. Beno,Bach Nga-Nguyen,Philip R. Kym,J.T. Link,Noah Tu,Dale S. Edgerton,Alan D. Cherrington,Suad Efendic,Benjamin C. Lane,T. J. Opgenorth +24 more
TL;DR: Overall, A-348441 demonstrates that an LSGRA is sufficient to reduce elevated HGO and normalize blood glucose and may provide a new therapeutic approach for the treatment of type 2 diabetes.